Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for OrthoPediatrics Corp. (KIDS : NSDQ)

• Company Description    OrthoPediatrics Corp. is a medical device company. It markets surgical systems for trauma and deformity, bone fractures and reconstruction procedures. OrthoPediatrics Corp. is based in NEW YORK. Number of Employees: 562

• Price / Volume Information    Yesterday's Closing Price: $22.45 Daily Weekly Monthly 20 Day Moving Average: 116,032 shares Shares Outstanding: 24.29 (millions) Market Capitalization: $545.23 (millions) Beta: 1.10 52 Week High: $35.99 52 Week Low: $19.52 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 3.36% -0.51% 12 Week 6.90% -10.08% Year To Date -3.15% -9.30%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2850 Frontier Drive - Warsaw,IN 46582 USA ph: 574-268-6379 fax: 574-269-3692 philip@gilmartinir.com http://www.orthopediatrics.com

• General Corporate Information    Officers David R. Bailey - President and Chief Executive Officer Fred L. Hite - Chief Financial Officer and Chief Operating Office Mark C. Throdahl - Director Bryan W. Hughes - Director Terry D. Schlotterback - Director Peer Information OrthoPediatrics Corp. (ABMD) OrthoPediatrics Corp. (DMDS) OrthoPediatrics Corp. (CPWY.) OrthoPediatrics Corp. (EQUR) OrthoPediatrics Corp. (ECIA) OrthoPediatrics Corp. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 68752L100 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/04/25 Share - Related Items Shares Outstanding: 24.29 Most Recent Split Date: (:1) Beta: 1.10 Market Capitalization: $545.23 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.14 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.24 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/04/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.57 Price/Cash Flow: - Price / Sales: 2.57 EPS Growth vs. Year Ago Period: -30.00% vs. Previous Quarter: -34.48% Sales Growth vs. Year Ago Period: 17.29% vs. Previous Quarter: -0.49% ROE 06/30/25 - - 03/31/25 - -7.03 12/31/24 - -6.33 ROA 06/30/25 - - 03/31/25 - -5.45 12/31/24 - -5.08 Current Ratio 06/30/25 - - 03/31/25 - 6.19 12/31/24 - 6.98 Quick Ratio 06/30/25 - - 03/31/25 - 2.99 12/31/24 - 3.54 Operating Margin 06/30/25 - - 03/31/25 - -11.95 12/31/24 - -11.35 Net Margin 06/30/25 - - 03/31/25 - -19.15 12/31/24 - -18.47 Pre-Tax Margin 06/30/25 - - 03/31/25 - -19.80 12/31/24 - -20.48 Book Value 06/30/25 - - 03/31/25 - 14.29 12/31/24 - 14.64 Inventory Turnover 06/30/25 - - 03/31/25 - 0.49 12/31/24 - 0.48 Debt-to-Equity 06/30/25 - - 03/31/25 - 0.21 12/31/24 - 0.20 Debt-to-Capital 06/30/25 - - 03/31/25 - 17.27 12/31/24 - 16.94

Powered by Zacks Investment Research ©